The resignation of Prudential Financial's Japan life insurance CEO following a widespread employee misconduct scandal has triggered governance reviews and shaken investor confidence in one of the insurer's key international markets.
As leveraged positions trigger a violent cross-asset selloff, ARK Invest founder Cathie Wood suggests gold's rally shows signs of a late-cycle bubble, pointing to extreme valuation metrics. The dramatic session saw nearly $9 trillion in market value swing across equities and metals.
Despite a recent 4.9% weekly pullback, shareholders of German-listed CHAPTERS Group (ETR:CHG) have seen staggering total returns exceeding 900% since 2019, fueled by explosive revenue growth. The journey highlights the potential rewards—and risks—of investing in high-growth, pre-profit companies.
Porsche has secured STARTRADER as the official partner for its Carrera Cup Middle East racing series, a strategic move to deepen engagement with performance-focused audiences in a key growth region, even as global delivery figures face headwinds.
Consumer goods giant Procter & Gamble has agreed to acquire Wonderbelly, a fast-growing brand in the 'free-from' digestive health space, signaling a deeper push into the lucrative wellness category and a bid to attract younger, label-conscious consumers.
Tesla CEO Elon Musk announced the end of production for the flagship Model S and Model X during the Q4 earnings call, marking a pivotal shift towards autonomous vehicle fleets and humanoid robot manufacturing.
Target is launching its largest-ever spring beauty collection, introducing over 3,000 new, predominantly budget-friendly items alongside redesigned in-store experiences and key leadership appointments, signaling a major strategic push to capture market share in the lucrative beauty sector.
Apple's fiscal Q1 2026 results, fueled by "staggering" demand for the iPhone 17, delivered record revenue and a dramatic turnaround in China, silencing critics and reigniting growth.
Flowco (NYSE: FLOC) has struck a deal to acquire Valiant Artificial Lift Solutions for $200 million, a move that significantly expands its electric submersible pump (ESP) capabilities in the key Permian Basin and broadens its production optimization portfolio.
South African insurer OUTsurance Group has rewarded long-term investors with a remarkable total shareholder return of 444% over the past five years, significantly outperforming its share price growth, driven by strong earnings and consistent dividends.
The Swiss-German residential real estate investor is projected to reach breakeven by late 2025, following years of substantial losses, as analysts forecast a sharp pivot to profitability.
A 19-year-old man faces kidnapping charges after allegedly grooming two sisters, ages 12 and 14, on popular online platforms and driving over 20 hours from Nebraska to Florida to meet them, authorities report.
A deep dive into Medios AG's shareholder structure shows private companies hold the largest block at 35%, giving them significant influence over the German healthcare services provider, while institutions own 26%.
Despite a modest rise in annual revenue, Mudajaya Group Berhad (KLSE:MUDAJYA) has seen its share price plummet 65% over five years, leaving long-term investors deep in the red. We examine the disconnect between business performance and market sentiment.
As income investors look toward 2026, a stark choice emerges between Energy Transfer's tempting 7.1% yield and Enterprise Products Partners' quarter-century record of reliable payouts. We examine the risk-reward calculus behind the numbers.
A Wells Fargo upgrade highlights ConocoPhillips' robust cash flow trajectory and strategic projects, positioning the energy giant for significant dividend growth over the next five years.
U.S. immigration authorities will not conduct enforcement actions at this Sunday's Super Bowl, sources tell Reuters, as the event becomes a flashpoint in the nation's heated immigration debate.
Vera Therapeutics appoints industry veteran Matt Skelton as Chief Commercial Officer, signaling a strategic pivot toward commercialization as its lead drug candidate for IgA nephropathy, atacicept, undergoes FDA Priority Review.
Despite stellar fundamentals and a dominant market position, Mastercard's premium valuation is prompting a debate among investors. While bulls champion its profitability and growth, skeptics warn of overextension, suggesting a pullback may offer a more attractive entry point.
Specialist asset manager Cohen & Steers (NYSE: CNS) is attracting bullish attention as its focus on real assets aligns with a shifting monetary policy landscape. After a prolonged period of outflows, the firm is seeing renewed investor interest.
